AlenCiken

FDA Emergency Use Authorization for SARS-CoV-2 N Protein Antigen

NASDAQ:QTRX   Quanterix Corporation
Quanterix Receives FDA Emergency Use Authorization for SARS-CoV-2 N Protein Antigen Test

As case counts and positivity rates rise globally, the COVID-19 testing landscape is of critical importance

finance.yahoo.com/ne...ation-213000735.html


免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。